U.S. markets closed
  • S&P 500

    +11.90 (+0.34%)
  • Dow 30

    -28.09 (-0.10%)
  • Nasdaq

    +42.28 (+0.37%)
  • Russell 2000

    +10.25 (+0.63%)
  • Crude Oil

    -0.86 (-2.12%)
  • Gold

    -1.20 (-0.06%)
  • Silver

    -0.01 (-0.04%)

    +0.0042 (+0.36%)
  • 10-Yr Bond

    -0.0070 (-0.83%)

    -0.0042 (-0.32%)

    -0.1200 (-0.11%)

    +227.91 (+1.77%)
  • CMC Crypto 200

    -1.40 (-0.54%)
  • FTSE 100

    +74.63 (+1.29%)
  • Nikkei 225

    +42.32 (+0.18%)

In Vitro Diagnostics (IVD) Quality Control Market Was Worth US$ 900 Million in 2019, Globally

·5 mins read

Active Industry Participants Include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Sero AS, Siemens Healthcare GmbH, Bio-Techne, Qiagen N.V., Sysmex Corp., Abbott Laboratories, Inc., Becton, Quidel Corp., Dickinson, and Company (BD), bioMerieux, Inc., Alere, Inc., Hologic, Inc. (Gen-Probe), and Roche Diagnostics

PUNE, India, Oct. 02, 2020 (GLOBE NEWSWIRE) -- The Global In Vitro Diagnostics (IVD) Quality Control Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis.

The In-Vitro Diagnostics Market size was estimated to be US$ 900 Million in 2019 and is expected to surpass US$ 1.4 billion by 2030. In-vitro diagnostics (IVDs) are the medical devices and equipment that are particularly manufactured so they can conduct in-vitro testing on body specimens such as urine, tissues, and blood. They are broadly employed for the detection and therapy of several medical illnesses. IVD quality controls are samples used to authenticate the trustworthiness of the IVD testing system to guarantee the precision of test outcomes and estimate the effect of factors such as environmental conditions and operator’s performance on test outcomes. This is credited to an increase in demand for third-party quality controls, rise in the number of qualified clinical labs, and strict orders from authorization institutes & governing organizations concerning the usage of controls.

View the complete report with Table of Contents : https://www.insightslice.com/report/in-vitro-diagnostics-ivd-quality-control-market/499

An escalating number of certified clinical labs worldwide and the presence of promising governing organizations are anticipated to be the main factors expanding the market growth. Diagnostic labs are observing fast advancement due to the huge predominance of disorders, such as diabetes, Cardiovascular Diseases (CVDs), and contagious illnesses. Many private, as well as public, labs are undergoing laboratory accreditation procedures to satisfy industry criteria, enhance their procedural volume, and lure more patients.

The immunology application segment is anticipated to register maximum growth rate

The global In Vitro Diagnostics (IVD) Quality Control market is segmented depending on application, type, end-use, and geography. By application, the IVD quality control market is divided into Immunochemistry, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others. The type segment is further divided into quality control, quality assurance services, data management. Based on end-use the market is segmented into hospitals, labs, home-care, and others.

Access the Sample of report : https://www.insightslice.com/request-sample/499

The immunology application segment led the global market in the year 2019. Immunology comprises the analysis of the molecular mechanism for understanding the role of the immune system. It mainly consists of the mechanism of antibodies, action of antigens, and their exchanges. Significant use of the immunochemistry comprise discovery of contagious microbes, like fungus, bacteria, and viruses, by discovering the occurrence of their coat and toxins antigens. An upsurge in the epidemics of contagious and chronic illnesses and the necessity for its initial identification are the major factors impelling the demand for immunochemistry methods.

Based on geography, the global In Vitro Diagnostics (IVD) Quality Control market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, the United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Indonesia, Australia, South Korea, Taiwan, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

Related report :

Global In-Vitro Fertilization (IVF) Market : https://www.insightslice.com/report/in-vitro-fertilization-ivf-market/327

Global Sepsis Diagnostics Market : https://www.insightslice.com/report/Sepsis-Diagnostic-Market---Global-Market-Share--Trends--Analysis-and-Forecasts--2020---2030/323

Global Telemedicine Market : https://www.insightslice.com/report/telemedicine-market/506

North America was the largest regional market in 2019 and estimated for maximum revenue share as a result of the existence of the United States FDA and many recognized diagnostic labs together with strong QC regulation structures. U.S. FDA accompanied by GHTF controls the North America region for the IVD QC market, from the making to pre- and post-marketing scrutiny.

The APAC region is estimated to be the rapidly developing region over the assessment timeline as the region has a huge potential for this market because of the growing number of product manufacturing corporations. Besides, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine has been boosting the application of IVDs. Therefore, an increase in consciousness for initial and accurate diagnosis promotes the product demand and ultimately the IVD quality control market in the region.

Major players active in the global In Vitro Diagnostics (IVD) Quality Control Market Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Sero AS, Siemens Healthcare GmbH, Bio-Techne, Qiagen N.V., Sysmex Corp., Abbott Laboratories, Inc., Becton, Quidel Corp., Dickinson, and Company (BD), bioMerieux, Inc., Alere, Inc., Hologic, Inc. (Gen-Probe), and Roche Diagnostics.

Buy this report : https://www.insightslice.com/buy-now/499

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details please contact our research and consulting team at info@insightslice.com.

Contact Us:



Phone (USA) : +1 707 736 6633 Email address : alex@insightslice.com

Web: www.insightslice.com